SIRT5 was shown to be overexpressed in advanced NSCLC and linked to poor prognosis in a study by Lu et al. that highlighted the possible function of SIRT5 in promoting lung cancer development and drug resistance [66]. This evidence concerns the gene SIRT5 and non-small cell lung carcinoma.